<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03308643</url>
  </required_header>
  <id_info>
    <org_study_id>2016/3</org_study_id>
    <nct_id>NCT03308643</nct_id>
  </id_info>
  <brief_title>Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy</brief_title>
  <official_title>Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effects of oxytocin infusion during abdominal myomectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myomectomy is indicated for symptomatic uterine fibroids. Fibroids have blood supply and 20%
      of the abdominal myomectomy cases might require blood transfusion because of the nature of
      the surgery. Oxytocin infusion is one of the intervention to decrease blood loss during
      myomectomy. To evaluate the effects and benefits of oxytocin infusion during abdominal
      myomectomy we decide to conduct this randomized study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Actual">May 10, 2018</completion_date>
  <primary_completion_date type="Actual">May 10, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The abdominal myomectomy cases will be randomized into 2 separate groups in a parallel fashion using an online software at 1:1 ratio.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Randomization will be performed by an online software and the list will be given to anesthesiologist so that neither the surgeon nor patient will know which intervention was performed. Randomized cards will be in sealed envelopes and will be open by anesthesiologist at the time of surgery.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss during surgery</measure>
    <time_frame>2 hours</time_frame>
    <description>estimated blood loss during the surgery measured by aspiration fluid.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss after abdominal myomectomy</measure>
    <time_frame>1 hour postoperatively</time_frame>
    <description>change in Hematocrit Percentage (before and after the surgery)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Myomectomy</condition>
  <arm_group>
    <arm_group_label>Oxytocin infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive pure normal saline infusion at the same rate and volume just before the surgery after the induction of general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.</description>
    <arm_group_label>Oxytocin infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>Patients will receive intravenous normal saline infusion just before the surgery after the induction of general anesthesia.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-50

          -  Patients who are candidate for abdominal myomectomy

        Exclusion Criteria:

          -  History of previous myomectomy.

          -  Suspected malignancy

          -  Patients with preoperative anemia

          -  Patients using hormonal treatments before the surgery.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients with uterus and undergoing abdominal myomectomy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berna Aslan</last_name>
    <role>Study Director</role>
    <affiliation>Kanuni Sultan Suleyman Research and Training Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kanuni Sultan Suleyman Egitim ve Arastırma Hastanesi</name>
      <address>
        <city>İstanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Atashkhoei S, Fakhari S, Pourfathi H, Bilehjani E, Garabaghi PM, Asiaei A. Effect of oxytocin infusion on reducing the blood loss during abdominal myomectomy: a double-blind randomised controlled trial. BJOG. 2017 Jan;124(2):292-298. doi: 10.1111/1471-0528.14416. Epub 2016 Nov 15.</citation>
    <PMID>27862855</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang FW, Yu MH, Ku CH, Chen CH, Wu GJ, Liu JY. Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy: a randomised controlled trial. BJOG. 2006 Jan;113(1):47-52.</citation>
    <PMID>16398771</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2017</study_first_submitted>
  <study_first_submitted_qc>October 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2017</study_first_posted>
  <last_update_submitted>May 17, 2018</last_update_submitted>
  <last_update_submitted_qc>May 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Berna Aslan Cetin</investigator_full_name>
    <investigator_title>Attending physician,ObGyn</investigator_title>
  </responsible_party>
  <keyword>myomectomy</keyword>
  <keyword>oxytocin</keyword>
  <keyword>blood loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

